Clinical Trial Update: Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine, cisplatin, epirubicin, and capecitabine in stage I–II resectable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ELLENCE (Epirubicin hydrochloride)
• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED